Circulating bacterial DNA and neutropenic fever during anti-leukaemia chemotherapy

Armin Rashidi, Thomas Kaiser, Maryam Ebadi, Shernan G. Holtan, Tauseef Ur Rehman, Daniel J. Weisdorf, Alexander Khoruts, Christopher Staley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)e55-e58
JournalBritish journal of haematology
Volume191
Issue number2
DOIs
StatePublished - Oct 1 2020

Bibliographical note

Funding Information:
Sequence data were processed and analyzed using the resources of the Minnesota Supercomputing Institute. AR was supported by a University of Minnesota Medical School Innovation award and the National Institutes of Health?s National Center for Advancing Translational Sciences, grants KL2TR002492 and UL1TR002494. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health?s National Center for Advancing Translational Sciences. TK received partial support from the University of Minnesota Masonic Cancer Center Chainbreaker grant. Additional funding from Achieving Cures Together and Hubbard Broadcasting Foundation supported this research.

Keywords

  • 16S
  • Delftia
  • acute leukemia
  • circulating bacteria
  • neutropenic fever

PubMed: MeSH publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Cite this